Activity of gefitinib in a non-small-cell lung cancer patient with both activating and resistance EGFR mutations

J Thorac Oncol. 2013 Jul;8(7):e59-60. doi: 10.1097/JTO.0b013e318286cc26.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Carcinoma, Large Cell / drug therapy
  • Carcinoma, Large Cell / genetics
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / genetics
  • Drug Resistance, Neoplasm / genetics*
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / genetics*
  • Gefitinib
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics
  • Male
  • Mutation / genetics*
  • Neoplasm Metastasis
  • Prognosis
  • Protein Kinase Inhibitors / therapeutic use*
  • Quinazolines / therapeutic use*

Substances

  • Protein Kinase Inhibitors
  • Quinazolines
  • EGFR protein, human
  • ErbB Receptors
  • Gefitinib